日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial

静脉注射羧基麦芽糖铁用于急性心力衰竭后伴或不伴糖尿病患者的铁补充:一项随机 AFFIRM-AHF 试验的亚组分析

Rosano, Giuseppe; Ponikowski, Piotr; Vitale, Cristiana; Anker, Stefan D; Butler, Javed; Fabien, Vincent; Filippatos, Gerasimos; Kirwan, Bridget-Anne; Macdougall, Iain C; Metra, Marco; Ruschitzka, Frank; Kumpeson, Vasuki; Goehring, Udo-Michael; van der Meer, Peter; Jankowska, Ewa A

Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function

铁羧基麦芽糖治疗伴有缺铁性心力衰竭和肾功能减退的住院患者

Macdougall, Iain C; Ponikowski, Piotr; Stack, Austin G; Wheeler, David C; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Göhring, Udo-Michael; Kirwan, Bridget-Anne; Kumpeson, Vasuki; Metra, Marco; Rosano, Giuseppe; Ruschitzka, Frank; van der Meer, Peter; Wächter, Sandra; Jankowska, Ewa A

Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data

铁缺乏与BNT162b2疫苗对SARS-CoV-2感染的有效性:一项基于真实世界数据的回顾性纵向分析

Tene, Lilac; Karasik, Avraham; Chodick, Gabriel; Pereira, Dora I A; Schou, Henrik; Waechter, Sandra; Göhring, Udo-Michael; Drakesmith, Hal

Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial

帕替罗默用于治疗接受肾素-血管紧张素-醛固酮系统抑制剂治疗心力衰竭患者的高钾血症:DIAMOND试验的设计和原理

Butler, Javed; Anker, Stefan D; Siddiqi, Tariq Jamal; Coats, Andrew J S; Dorigotti, Fabio; Filippatos, Gerasimos; Friede, Tim; Göhring, Udo-Michael; Kosiborod, Mikhail N; Lund, Lars H; Metra, Marco; Moreno Quinn, Carol; Piña, Ileana L; Pinto, Fausto J; Rossignol, Patrick; Szecsödy, Peter; Van Der Meer, Peter; Weir, Matthew; Pitt, Bertram

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency

羧基麦芽糖铁可改善射血分数降低和缺铁性心力衰竭患者的健康状况

Butler, Javed; Khan, Muhammad Shahzeb; Friede, Tim; Jankowska, Ewa A; Fabien, Vincent; Goehring, Udo-Michael; Dorigotti, Fabio; Metra, Marco; Piña, Ileana L; Coats, Andrew J S; Rosano, Giuseppe; Comin-Colet, Josep; Van Veldhuisen, Dirk J; Filippatos, Gerasimos S; Anker, Stefan D; Ponikowski, Piotr

Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency

对射血分数降低且伴有缺铁的心力衰竭患者使用羧基麦芽糖铁治疗后6分钟步行试验改善情况的反应者分析

Anker, Stefan D; Ponikowski, Piotr; Khan, Muhammad Shahzeb; Friede, Tim; Jankowska, Ewa A; Fabien, Vincent; Goehring, Udo-Michael; Metra, Marco; Piña, Ileana L; Coats, Andrew J S; Rosano, Giuseppe; Dorigotti, Fabio; Comin-Colet, Josep; Van Veldhuisen, Dirk J; Filippatos, Gerasimos S; Butler, Javed

Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers

口服铁转运蛋白抑制剂VIT-2763:首次人体试验,在健康志愿者中进行的1期临床试验

Richard, Frank; van Lier, Jan Jaap; Roubert, Bernard; Haboubi, Teba; Göhring, Udo-Michael; Dürrenberger, Franz

A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose

对 45 项使用羧基麦芽糖铁干预试验中血清磷酸盐测量值和潜在低磷血症事件的汇总分析

Rosano, Giuseppe; Schiefke, Ingolf; Göhring, Udo-Michael; Fabien, Vincent; Bonassi, Stefano; Stein, Jürgen

Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

采用随机分组的环索奈德剂量(160、320 和 640 μg/天)控制中重度哮喘。

Pedersen, Søren E; Prasad, Niyati; Goehring, Udo-Michael; Andersson, Henrik; Postma, Dirkje S